Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Boyce

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
Cell|May 19, 1995
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activityH Zheng, M Jiang, M E Trumbauer, et al.
Movement Ecology|August 6, 2024
A protocol for assessing bias and robustness of social network metrics using GPS based radio-telemetry dataPrabhleen Kaur, Simone Ciuti, Federico Ossi, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2020
Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitorsSavithri Ramurthy, Keith B Pfister, Rustum S Boyce, et al.
Ecology|April 2, 2008
Longevity can buffer plant and animal populations against changing climatic variabilityWilliam F Morris, Catherine A Pfister, Shripad Tuljapurkar, et al.
British Journal of Pharmacology|May 1, 1997
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitorD Riendeau, M D Percival, S Boyce, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profilesC C Chan, S Boyce, C Brideau, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2D Riendeau, M D Percival, C Brideau, et al.
Journal of Medicinal Chemistry|October 11, 2017
Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3Allan S Wagman, Rustum S Boyce, Sean P Brown, et al.
Nature Ecology & Evolution|December 5, 2024
Neonatal antipredator tactics shape female movement patterns in large herbivoresKamal Atmeh, Christophe Bonenfant, Jean-Michel Gaillard, et al.
Global Ecology and Biogeography : a Journal of Macroecology|October 17, 2022
Evaluating expert-based habitat suitability information of terrestrial mammals with GPS-tracking dataMaarten J E Broekman, Jelle P Hilbers, Mark A J Huijbregts, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Cell|May 19, 1995
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activityH Zheng, M Jiang, M E Trumbauer, et al.
Movement Ecology|August 6, 2024
A protocol for assessing bias and robustness of social network metrics using GPS based radio-telemetry dataPrabhleen Kaur, Simone Ciuti, Federico Ossi, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2020
Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitorsSavithri Ramurthy, Keith B Pfister, Rustum S Boyce, et al.
Ecology|April 2, 2008
Longevity can buffer plant and animal populations against changing climatic variabilityWilliam F Morris, Catherine A Pfister, Shripad Tuljapurkar, et al.
British Journal of Pharmacology|May 1, 1997
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitorD Riendeau, M D Percival, S Boyce, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profilesC C Chan, S Boyce, C Brideau, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2D Riendeau, M D Percival, C Brideau, et al.
Journal of Medicinal Chemistry|October 11, 2017
Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3Allan S Wagman, Rustum S Boyce, Sean P Brown, et al.
Nature Ecology & Evolution|December 5, 2024
Neonatal antipredator tactics shape female movement patterns in large herbivoresKamal Atmeh, Christophe Bonenfant, Jean-Michel Gaillard, et al.
Global Ecology and Biogeography : a Journal of Macroecology|October 17, 2022
Evaluating expert-based habitat suitability information of terrestrial mammals with GPS-tracking dataMaarten J E Broekman, Jelle P Hilbers, Mark A J Huijbregts, et al.
Pageof 22